Krishnaraj Rajalingam

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Katarzyna Bogucka-Janczi, Gregory Harms, Marie-May Coissieux, Mohamed Bentires-Alj, Bernd Thiede, Krishnaraj Rajalingam
ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization. eLife 12 (2023)
Madeleine Eichler, Ute Distler, Usman Nasrullah, Aswini Krishnan, Manuel Kaulich, Koraljka Husnjak, Wolfgang Eberhardt, Krishnaraj Rajalingam, Stefan Tenzer, Josef Pfeilschifter, Gergely Imre
The caspase-2 substrate p54nrb exhibits a multifaceted role in tumor cell death susceptibility via gene regulatory functions. Cell death & disease 13 (4) (2022)
Juliane Mooz, Kristina Riegel, Hari Ps, Anguraj Sadanandam, Federico Marini, Matthias Klein, Ulrike Werner, Wilfried Roth, Annett Wilken-Schmitz, Irmgard Tegeder, Krishnaraj Rajalingam
ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers. Science advances 8 (11) (2022)
Niclas Fester, Elisabeth Zielonka, Jakob Goldmann, Ann-Sophie Frombach, Uta Müller-Kuller, Niklas Gutfreund, Kristina Riegel, Jos G A Smits, Enrico Schleiff, Krishnaraj Rajalingam, Huiqing Zhou, Stefan Simm, Volker Dötsch
Enhanced pro-apoptosis gene signature following the activation of TAp63α in oocytes upon γ irradiation. Cell death & disease 13 (3) (2022)
Marcel Hahn, Adriana Covarrubias-Pinto, Lina Herhaus, Shankha Satpathy, Kevin Klann, Keith B Boyle, Christian Münch, Krishnaraj Rajalingam, Felix Randow, Chunaram Choudhary, Ivan Dikic
SIK2 orchestrates actin-dependent host response upon Salmonella infection. Proceedings of the National Academy of Sciences of the United States of America 118 (19) (2021)
Kristina Riegel, Hajime Yurugi, Janine Schlöder, Helmut Jonuleit, Manuel Kaulich, Friederike Kirschner, Danielle Arnold-Schild, Stefan Tenzer, Hansjörg Schild, Krishnaraj Rajalingam
ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression. Cell death & disease 12 (11) (2021)
Camille Amandine Dupont, Kristina Riegel, Malvika Pompaiah, Hartmut Juhl, Krishnaraj Rajalingam
Druggable genome and precision medicine in cancer: current challenges. The FEBS journal 288 (21) (2021)
Hajime Yurugi, Yinyin Zhuang, Farid A Siddiqui, Hong Liang, Sebastian Rosigkeit, Yongpeng Zeng, Hussein Abou-Hamdan, Ernesto Bockamp, Yong Zhou, Daniel Abankwa, Wenting Zhao, Laurent Désaubry, Krishnaraj Rajalingam
A subset of flavaglines inhibits KRAS nanoclustering and activation. Journal of cell science 133 (12) (2020)
Dong Wang, Redouane Tabti, Sabria Elderwish, Hussein Abou-Hamdan, Amel Djehal, Peng Yu, Hajime Yurugi, Krishnaraj Rajalingam, Canan G Nebigil, Laurent Désaubry
Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases. Cellular and molecular life sciences : CMLS 77 (18) (2020)
Lisa J Crawford, David C Campbell, Jonathan J Morgan, Michelle A Lawson, Jennifer M Down, Dharminder Chauhan, Roisin M McAvera, Treen C Morris, Claudia Hamilton, Aswini Krishnan, Krishnaraj Rajalingam, Andrew D Chantry, Alexandra E Irvine
The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma. Oncogene 39 (27) (2020)
Donghyuk Shin, Rukmini Mukherjee, Diana Grewe, Denisa Bojkova, Kheewoong Baek, Anshu Bhattacharya, Laura Schulz, Marek Widera, Ahmad Reza Mehdipour, Georg Tascher, Paul P Geurink, Alexander Wilhelm, Gerbrand J van der Heden van Noort, Huib Ovaa, Stefan Müller, Klaus-Peter Knobeloch, Krishnaraj Rajalingam, Brenda A Schulman, Jindrich Cinatl, Gerhard Hummer, Sandra Ciesek, Ivan Đikić
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587 (7835) (2020)
Katarzyna Bogucka, Malvika Pompaiah, Federico Marini, Harald Binder, Gregory Harms, Manuel Kaulich, Matthias Klein, Christian Michel, Markus P Radsak, Sebastian Rosigkeit, Peter Grimminger, Hansjörg Schild, Krishnaraj Rajalingam
ERK3/MAPK6 controls IL-8 production and chemotaxis. eLife 9 (2020)
Aswini Krishnan, Jean Berthelet, Emilie Renaud, Sebastian Rosigkeit, Ute Distler, Eric Stawiski, Jing Wang, Zora Modrusan, Marc Fiedler, Mariann Bienz, Stefan Tenzer, Arno Schad, Wilfried Roth, Bernd Thiede, Somasekar Seshagiri, Thomas J Musholt, Krishnaraj Rajalingam
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas. Nature communications 11 (1) (2020)
Katarzyna Bogucka-Janczi, Federico Marini, Sebastian Rosigkeit, Janine Schloeder, Helmut Jonuleit, Kerstin David, Margarita Schlackow, Krishnaraj Rajalingam
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Cancer gene therapy 28 (5) (2020)
Anguraj Sadanandam, Tobias Bopp, Santosh Dixit, David J H F Knapp, Chitra Priya Emperumal, Paschalis Vergidis, Krishnaraj Rajalingam, Alan Melcher, Nagarajan Kannan
A blood transcriptome-based analysis of disease progression, immune regulation, and symptoms in coronavirus-infected patients. Cell death discovery 6 (1) (2020)
Katarzyna Bogucka-Janczi, Federico Marini, Sebastian Rosigkeit, Janine Schloeder, Helmut Jonuleit, Kerstin David, Margarita Schlackow, Krishnaraj Rajalingam
Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Cancer gene therapy (2020)
Ulrike Buehler, Katharina Schulenburg, Hajime Yurugi, Maja Šolman, Daniel Abankwa, Alexander Ulges, Stefan Tenzer, Tobias Bopp, Bernd Thiede, Frauke Zipp, Krishnaraj Rajalingam
Targeting prohibitins at the cell surface prevents Th17-mediated autoimmunity. The EMBO journal 37 (16) (2018)
Gergely Imre, Jean Berthelet, Jan Heering, Sebastian Kehrloesser, Inga Maria Melzer, Byung Il Lee, Bernd Thiede, Volker Dötsch, Krishnaraj Rajalingam
Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2. EMBO reports 18 (5) (2017)

Krishnaraj Rajalingam.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Krishnaraj Rajalingam